- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 9033
10-year publication summary
|
247
|
391
|
506
|
513
|
503
|
628
|
615
|
597
|
538
|
120
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
290 |
| Bristol-myers Squibb Company | 4793 |
152 |
| F. Hoffmann-La Roche AG | 7882 |
132 |
| Novartis AG | 10463 |
116 |
| Genentech, Inc. | 4058 |
74 |
| Incyte Corporation | 1046 |
73 |
| Boehringer Ingelheim International GmbH | 4576 |
62 |
| Hoffmann-La Roche Inc. | 3640 |
61 |
| Merck Patent GmbH | 5741 |
48 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
48 |
| Janssen Pharmaceutica N.V. | 3298 |
42 |
| Takeda Pharmaceutical Company Limited | 2722 |
42 |
| Glaxo Group Limited | 4264 |
41 |
| The Regents of the University of California | 20447 |
38 |
| Glaxosmithkline Intellectual Property Development Limited | 773 |
38 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 670 |
38 |
| AstraZeneca AB | 2824 |
37 |
| Jiangsu Hengrui Medicine Co., Ltd. | 700 |
34 |
| Pfizer Inc. | 3377 |
33 |
| Bayer Pharma AG | 1035 |
33 |
| Other owners | 7601 |